Rich Horgan: How A Nonprofit Pharma Company Is Using CRISPR To Cure Muscular Dystrophy
Menu
Rich Horgan, How A Nonprofit Pharma Company Is Using CRISPR To Cure Muscular Dystrophy
Many of us face challenging medical diagnoses, and those with rare diseases often get the news without any treatment options. Rich Horgan’s family has been fighting his brother’s Duchenne Muscular Dystrophy (DMD) diagnosis for over two decades. Rich’s relentless dedication to helping his brother Terry led him to leave Harvard Business School to create the first nonprofit drug company to use CRISPR to cure DMD. Rich shares his journey, the future of personalized gene therapy and how he built an organization to save not only his own brother, but other patients fighting these incurable diseases.
© 2020- 2021 All Right Reserved. Developed By Hummingbird Radio
